Feasibility of structuring electronic health record data to facilitate real-world data research: ICAREdata methods applied to multicenter cancer clinical trials
View abstract on PubMed
Summary
This summary is machine-generated.Structuring electronic health record (EHR) data using the minimal Common Oncology Data Elements (mCODE) model is feasible for cancer clinical trials. The ICAREdata project demonstrated this approach can improve data extraction and sharing for research.
Area Of Science
- Oncology
- Health Informatics
- Clinical Trials
Background
- Electronic health record (EHR) data often lacks structure and standardization, hindering its use in research.
- The Integrating Clinical Trials and Real-World Endpoints Data (ICAREdata) project aimed to address this by structuring EHR data.
Purpose Of The Study
- To structure key research data elements within EHRs using the minimal Common Oncology Data Elements (mCODE) data model.
- To extract and transmit this structured data for research purposes.
Main Methods
- The ICAREdata project focused on capturing cancer disease status and treatment plan changes from EHRs.
- Data were extracted from clinical sites using Fast Healthcare Interoperability Resource (FHIR) messaging and compared against electronic data capture (EDC) systems.
- Implementation occurred in sites participating in Alliance for Clinical Trials in Oncology trials.
Main Results
- Data extraction and transmission were completed from 10 sites for 35 patients across 15 trials.
- Concordance rates for treatment plan change and cancer disease status were 79% and 34%, respectively.
- Agreement on cancer disease status reached 87% when evaluated by both EHR and EDC systems.
Conclusions
- Structuring EHR data using mCODE and ICAREdata methods is achievable in multi-institutional cancer clinical trials.
- EDC systems serve as valuable references for assessing EHR data completeness.
- Future efforts will prioritize elements with shared definitions and streamlined workflows.
Related Concept Videos
Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare...
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

